Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020;382(8):727–33.
Article CAS PubMed Google Scholar
Hossain MJ, Ahmmed F, Rahman SMA, Sanam S, Emran TB, Mitra S. Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh. Heliyon. 2021;7(6):e07388.
Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical outcomes of a COVID-19 vaccine: implementation over efficacy. Health Aff (Millwood). 2021;40(1):42–52.
Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, et al. SARS-CoV-2 reinfection and implications for vaccine development. Hum Vaccin Immunother. 2020;16(12):3061–73.
Article CAS PubMed Google Scholar
Tareq AM, Emran TB, Dhama K, Dhawan M, Tallei TE. Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic. Hum Vaccin Immunother. 2021;17(11):4126–7.
Article CAS PubMed PubMed Central Google Scholar
Orhan IE, Senol Deniz FS. Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2?. Nat Prod Bioprospect. 2020;10(4):171–86.
Article CAS PubMed PubMed Central Google Scholar
Şimşek Yavuz S, Ünal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020;50(Si-1):611–9.
Article PubMed PubMed Central Google Scholar
NIH. Table 4d. Characteristics of Antiviral Agents: National Institutes of Health; 2022 [updated 8 Aug 2022. Available from: https://www.covid19treatmentguidelines.nih.gov/tables/antiviral-characteristics/. Cited 7 Sept 2022.
Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222(6):521–31.
Article CAS PubMed PubMed Central Google Scholar
Kumar R, Yeni CM, Utami NA, Masand R, Asrani RK, Patel SK, et al. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies-a narrative review. J Infect Public Health. 2021;14(7):863–75.
Article PubMed PubMed Central Google Scholar
Whitehead CL, Walker SP. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials. Lancet. 2020;395(10237):e92.
Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, et al. Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses. Pathogens. 2021;10(5):565.
Article CAS PubMed PubMed Central Google Scholar
Wang J, Li Q, Qiu Y, Lu H. COVID-19: imbalanced cell-mediated immune response drives to immunopathology. Emerg Microbes Infect. 2022;11(1):2393–404.
Article CAS PubMed PubMed Central Google Scholar
El Gizawy HA, Boshra SA, Mostafa A, Mahmoud SH, Ismail MI, Alsfouk AA, et al. Pimenta dioica (L.) Merr. Bioactive constituents exert anti-SARS-CoV-2 and anti-inflammatory activities: Molecular docking and dynamics, in vitro, and in vivo studies. Molecules. 2021;26(19):5844.
Article PubMed PubMed Central Google Scholar
Soltane R, Chrouda A, Mostafa A, Al-Karmalawy AA, Chouaïb K, Dhahri A, et al. Strong inhibitory activity and action modes of synthetic maslinic acid derivative on highly pathogenic coronaviruses: COVID-19 drug candidate. Pathogens. 2021;10(5):623.
Article CAS PubMed PubMed Central Google Scholar
Kanjanasirirat P, Suksatu A, Manopwisedjaroen S, Munyoo B, Tuchinda P, Jearawuttanakul K, et al. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Sci Rep. 2020;10(1):19963.
Article CAS PubMed PubMed Central Google Scholar
Kushwaha PP, Singh AK, Bansal T, Yadav A, Prajapati KS, Shuaib M, et al. Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach. Front Cell Infect Microbiol. 2021;11:730288.
Article CAS PubMed PubMed Central Google Scholar
Nair MS, Huang Y, Fidock DA, Polyak SJ, Wagoner J, Towler MJ, et al. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. J Ethnopharmacol. 2021;274:114016.
Orege JI, Adeyemi SB, Tiamiyu BB, Akinyemi TO, Ibrahim YA, Orege OB. Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective. Adv Tradition Med. 2023;23(1):85–96.
Sa-ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, et al. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod. 2021;84:1261–70.
Article CAS PubMed Google Scholar
Baeshen MN, Attar R, Bouback TA, Albeshri AO, Baeshen NN, Karkashan A, et al. Assaying for antiviral activity of the folkloric medicinal desert plant Rhazya stricta on coronavirus SARS-CoV-2. Biotechnol Biotechnol Equip. 2022;36(1):68–74.
Darwish RS, El-Banna AA, Ghareeb DA, El-Hosseny MF, Seadawy MG, Dawood HM. Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) cultivars using UPLC-MS/MS coupled to chemometric analysis, in vitro study and molecular docking. J Ethnopharmacol. 2022;291:115038.
Nie C, Trimpert J, Moon S, Haag R, Gilmore K, Kaufer BB, et al. In vitro efficacy of Artemisia extracts against SARS-CoV-2. Virol J. 2021;18(1):182.
Article CAS PubMed PubMed Central Google Scholar
Zhao S, Huang AS, Zhang W, Ren L, Wang H, Wang J, et al. Screening and identifying natural products with SARS-CoV-2 infection inhibitory activity from medicinal fungi. Biosafety Health. 2024;6(1):12–20.
Liskova A, Samec M, Koklesova L, Samuel SM, Zhai K, Al-Ishaq RK, et al. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother. 2021;138:111430.
Mahmud S, Paul GK, Afroze M, Islam S, Gupt SBR, Razu MH, et al. Efficacy of phytochemicals derived from Avicennia officinalis for the management of COVID-19: A combined in silico and biochemical study. Molecules. 2021;26(8):2210.
Article CAS PubMed PubMed Central Google Scholar
Rakib A, Paul A, Chy MNU, Sami SA, Baral SK, Majumder M, et al. Biochemical and computational approach of selected phytocompounds from Tinospora crispa in the management of COVID-19. Molecules. 2020;25:3936.
Article CAS PubMed PubMed Central Google Scholar
Tallei TE, Fatimawali, Niode NJ, Idroes R, Zidan B, Mitra S, et al. A Comprehensive review of the potential use of green tea polyphenols in the management of COVID-19. Evid Based Complement Alternat Med. 2021;2021:7170736.
Yang JY, Ma YX, Liu Y, Peng XJ, Chen XZ. A comprehensive review of natural flavonoids with anti-SARS-CoV-2 activity. Molecules. 2023;28(6):2735.
Article CAS PubMed PubMed Central Google Scholar
Wanaratna K, Leethong P, Inchai N, Chueawiang W, Sriraksa P, Tabmee A, et al. Efficacy and safety of andrographis paniculata extract in patients with mild COVID-19: a randomized controlled trial. Arch Intern Med Res. 2022;5:423–7.
Tanwettiyanont J, Piriyachananusorn N, Sangsoi L, Boonsong B, Sunpapoa C, Tanamatayarat P, et al. Use of Andrographis paniculata (Burm.f.) Wall. ex Nees and risk of pneumonia in hospitalised patients with mild coronavirus disease 2019: a retrospective cohort study. Front Med. 2022;9:947373.
Su M, Shi D, Xing X, Qi S, Yang D, Zhang J, et al. Coronavirus porcine epidemic diarrhea virus nucleocapsid protein interacts with p53 to induce cell cycle arrest in s-phase and promotes viral replication. J Virol. 2021;95(16):e00187–221.
Article CAS PubMed PubMed Central Google Scholar
Song Y, Singh P, Nelson E, Ramamoorthy S. A computationally designed serological assay for porcine epidemic diarrhea virus. J Clin Microbiol. 2016;54(8):2039–46.
Article CAS PubMed PubMed Central Google Scholar
Lin F, Zhang H, Li L, Yang Y, Zou X, Chen J, et al. PEDV: Insights and advances into types, function, structure, and receptor recognition. Viruses. 2022;14(8):1744.
留言 (0)